Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15302
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Different Treatment Choice for First-Line Treatment of Helicobacter Pylori in an Area With a High Antibiotic Resistance

Turkish Journal of Gastroenterology
Gastroenterology
2015English

Clinical Efficacy of Gemifloxacin-Containing Triple Therapy for First-Line Treatment of Helicobacter Pylori Infection: A Pilot Study

The Korean Journal of Helicobacter and Upper Gastrointestinal Research
2017English

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori

Gastroenterology Research and Practice
HepatologyGastroenterology
2017English

Efficacy of Potassium-Competitive Acid Blocker vs Proton Pump Inhibitor as First-Line and Second-Line Treatment for Helicobacter Pylori Eradication

Open Journal of Gastroenterology and Hepatology
2019English

Lactobacillus Reuteri – An Alternative in the First-Line of Helicobacter Pylori Eradication

Farmacia
ToxicologyPharmaceuticsPharmacology
2019English

14 Day-Sequential, Concomitant, and Hybrid Therapies for First-Line Helicobacter Pylori (H. PYLORI) Eradication: A Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

First-Line Helicobacter Pylori Eradication in Patients With Chronic Kidney Diseases in Taiwan

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

Treatment of Helicobacter Pylori Infection

Helicobacter
MedicineInfectious DiseasesGastroenterology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy